Want to see HK:0474 full AI Analyst Report?

Aceso Life Science Group Limited (0474) Financial Statements

0 Followers

Aceso Life Science Group Limited Financial Overview

Aceso Life Science Group Limited's market cap is currently HK$1.33B. The company's EPS TTM is HK$0.0473; its P/E ratio is 3.17; and it has a dividend yield of 1.20%. Aceso Life Science Group Limited is scheduled to report earnings on June 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Income Statement
Total Revenue	HK$ 64.00M	HK$ 195.00M	HK$ 11.00M	HK$ 312.00M	HK$ 315.00M
Gross Profit	HK$ 54.00M	HK$ 90.00M	HK$ -100.00M	HK$ 141.00M	HK$ 162.00M
Operating Income	HK$ 40.00M	HK$ -24.00M	HK$ -224.00M	HK$ -153.00M	HK$ 10.00M
EBITDA	HK$ -297.00M	HK$ -860.00M	HK$ -220.00M	HK$ -21.00M	HK$ -359.00M
Net Income	HK$ 338.00M	HK$ -895.00M	HK$ -462.00M	HK$ -264.00M	HK$ -370.00M
Balance Sheet
Cash & Short-Term Investments	HK$ 345.00M	HK$ 207.00M	HK$ 466.00M	HK$ 602.00M	HK$ 717.00M
Total Assets	HK$ 1.79B	HK$ 3.24B	HK$ 4.79B	HK$ 6.30B	HK$ 6.26B
Total Debt	HK$ 1.19B	HK$ 2.30B	HK$ 2.74B	HK$ 2.34B	HK$ 3.01B
Net Debt	HK$ 1.04B	HK$ 2.17B	HK$ 2.37B	HK$ 2.16B	HK$ 2.81B
Total Liabilities	HK$ 1.33B	HK$ 2.50B	HK$ 2.97B	HK$ 3.73B	HK$ 3.44B
Stockholders' Equity	HK$ 457.00M	HK$ 12.00M	HK$ 921.00M	HK$ 1.55B	HK$ 2.00B
Cash Flow
Free Cash Flow	HK$ 20.00M	HK$ 15.00M	HK$ -48.00M	HK$ 175.00M	HK$ 259.00M
Operating Cash Flow	HK$ 20.00M	HK$ 17.00M	HK$ -37.00M	HK$ 222.00M	HK$ 316.00M
Investing Cash Flow	HK$ 674.00M	HK$ 337.00M	HK$ 472.00M	HK$ -120.00M	HK$ -441.00M
Financing Cash Flow	HK$ -681.00M	HK$ -587.00M	HK$ 117.00M	HK$ -98.00M	HK$ 126.00M

Currency in HKD

Aceso Life Science Group Limited Earnings and Revenue History

Income Statement >

Aceso Life Science Group Limited Debt to Assets

Balance Sheet >

Aceso Life Science Group Limited Cash Flow

Cash Flow >

Aceso Life Science Group Limited Forecast EPS vs Actual EPS

Earnings >